Provider variability in the intraoperative use of neuromuscular blocking agents: a retrospective multicentre cohort study.

adult anaesthesia clinical pharmacology health & safety neuromuscular disease

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
14 04 2021
Historique:
entrez: 15 4 2021
pubmed: 16 4 2021
medline: 21 5 2021
Statut: epublish

Résumé

To assess variability in the intraoperative use of non-depolarising neuromuscular blocking agents (NMBAs) across individual anaesthesia providers, surgeons and hospitals. Retrospective observational cohort study. Two major tertiary referral centres, Boston, Massachusetts, USA. 265 537 adult participants undergoing non-cardiac surgery between October 2005 and September 2017. We analysed the variances in NMBA use across 958 anaesthesia and 623 surgical providers, across anaesthesia provider types (anaesthesia residents, certified registered nurse anaesthetists, attendings) and across hospitals using multivariable-adjusted mixed effects logistic regression. Intraclass correlations (ICC) were calculated to further quantify the variability in NMBA use that was unexplained by other covariates. Procedure-specific subgroup analyses were performed. NMBAs were used in 183 242 (69%) surgical cases. Variances in NMBA use were significantly higher among individual surgeons than among anaesthesia providers (variance 1.32 (95% CI 1.06 to 1.60) vs 0.24 (95% CI 0.19 to 0.28), p<0.001). Procedure-specific subgroup analysis of hernia repairs, spine surgeries and mastectomies confirmed our findings: the total variance in NMBA use that was unexplained by the covariate model was higher for surgeons versus anaesthesia providers (ICC 37.0% vs 13.0%, 69.7% vs 25.5%, 69.8% vs 19.5%, respectively; p<0.001). Variances in NMBA use were also partially explained by the anaesthesia provider's hospital network (Massachusetts General Hospital: variance 0.35 (95% CI 0.27 to 0.43) vs Beth Israel Deaconess Medical Center: 0.15 (95% CI 0.12 to 0.19); p<0.001). Across provider types, surgeons showed the highest variance, and anaesthesia residents showed the lowest variance in NMBA use. There is wide variability across individual surgeons and anaesthesia providers and institutions in the use of NMBAs, which could not sufficiently be explained by a large number of patient-related and procedure-related characteristics, but may instead be driven by preference. Surgeons may have a stronger influence on a key aspect of anaesthesia management than anticipated.

Identifiants

pubmed: 33853808
pii: bmjopen-2020-048509
doi: 10.1136/bmjopen-2020-048509
pmc: PMC8054197
doi:

Substances chimiques

Neuromuscular Blocking Agents 0

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e048509

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: TTH reports grants from NINDS (PI), grants from NIGMS, personal fees from Headache, personal fees from Anesthesiology, personal fees from Cephalalgia, outside the submitted work. ME received honorarium for giving advice to Merck, holds equity of Calabash Bioscience and is an Associate Editor of the British Journal of Anaesthesia.

Références

F1000Res. 2018 Feb 9;7:167
pubmed: 29497496
Anesthesiology. 2000 Dec;93(6):1392-7
pubmed: 11149431
Anesth Analg. 2019 Jun;128(6):1129-1136
pubmed: 31094777
Anesth Analg. 2011 Nov;113(5):1197-201
pubmed: 21821510
BMJ Qual Saf. 2020 Oct 7;:
pubmed: 33028658
Br J Anaesth. 2005 Nov;95(5):622-6
pubmed: 16183681
Anesth Analg. 2019 Jun;128(6):1118-1126
pubmed: 31094776
Eur J Anaesthesiol. 2019 Jul;36(7):486-493
pubmed: 30985536
Acta Anaesthesiol Scand. 2015 Jan;59(1):1-16
pubmed: 25328055
Lancet Respir Med. 2019 Feb;7(2):129-140
pubmed: 30224322
J Neurosurg Anesthesiol. 2014 Jan;26(1):45-9
pubmed: 23887680
J Clin Monit Comput. 2019 Jun;33(3):455-462
pubmed: 30094585
Br J Anaesth. 2021 Mar;126(3):738-745
pubmed: 33341223
N Engl J Med. 2019 May 23;380(21):1997-2008
pubmed: 31112383
Anesth Analg. 2010 Jul;111(1):120-8
pubmed: 20442260
Acta Anaesthesiol Scand. 2020 Feb;64(2):156-167
pubmed: 31529484
Anaesthesia. 2001 Apr;56(4):312-8
pubmed: 11284816
Br J Anaesth. 2017 Oct 1;119(4):595-605
pubmed: 29121289
Anesthesiology. 2015 Jun;122(6):1201-13
pubmed: 25919486
Curr Opin Anaesthesiol. 2009 Dec;22(6):730-7
pubmed: 19752726
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Acta Anaesthesiol Scand. 1997 Oct;41(9):1095-1103
pubmed: 9366929
Anesth Analg. 2018 Feb;126(2):503-512
pubmed: 28763357

Auteurs

Friederike C Althoff (FC)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Xinling Xu (X)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Luca J Wachtendorf (LJ)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Denys Shay (D)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Maria Patrocinio (M)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Maximilian S Schaefer (MS)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Department of Anesthesiology, Duesseldorf University Hospital, Duesseldorf, Germany.

Timothy T Houle (TT)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Philipp Fassbender (P)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Klinik für Anästhesiologie, Operative Intensivmedizin, Schmerz- und Palliativmedizin, Marien Hospital Herne, Universitätsklinikum der Ruhr-Universität Bochum, Bochum, Germany.

Matthias Eikermann (M)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA meikermann@montefiore.org.
Department of Anesthesiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.

Karuna Wongtangman (K)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH